In a regulatory filing, Quanterix (QTRX) disclosed that its director William Donnely bought 93.1K shares of common stock on June 6th in a total transaction size of $506K.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTRX:
- Akoya Biosciences price target lowered to $1.14 from $3 at Morgan Stanley
- Hold Rating on Quanterix Amid Merger Uncertainties and Economic Pressures
- Akoya Biosciences price target lowered to $1.08 from $1.80 at Canaccord
- Quanterix’s Earnings Call: Resilience Amid Challenges
- Quanterix Faces Revenue Challenges Amid Project Delays and Tariff Impacts, Holds Rating Due to Cautious Outlook